Compare · HERA vs ORIA
HERA vs ORIA
Side-by-side comparison of FTAC Hera Acquisition Corp. (HERA) and Orion Biotech Opportunities Corp. (ORIA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HERA and ORIA operate in Blank Checks (Finance), so they compete in similar markets.
- HERA is the larger of the two at $1.06B, about 4.4x ORIA ($242.0M).
HERA
FTAC Hera Acquisition Corp.
FTAC Hera Acquisition Corp. is a blank check company. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.
ORIA
Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Latest HERA
- SEC Form SC 13G/A filed by FTAC Hera Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by FTAC Hera Acquisition Corp. (Amendment)
- SEC Form 25-NSE filed by FTAC Hera Acquisition Corp.
- FTAC Hera Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- FTAC Hera Acquisition Corp. Announces it Will Redeem its Public Shares
- SEC Form SC 13G filed by FTAC Hera Acquisition Corp.
- SEC Form SC 13G filed by FTAC Hera Acquisition Corp.
- SEC Form SC 13G filed by FTAC Hera Acquisition Corp.
- SEC Form SC 13G/A filed by FTAC Hera Acquisition Corp. (Amendment)
- FTAC Hera Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
Latest ORIA
- SEC Form SC 13G/A filed by Orion Biotech Opportunities Corp. (Amendment)
- SEC Form 4 filed by Collins James J.
- SEC Form 4 filed by Broder Samuel
- SEC Form 4 filed by Orion Sponsor Holdings, Llc
- SEC Form 4 filed by Rodriguez Louisa
- SEC Form 15-12G filed by Orion Biotech Opportunities Corp.
- SEC Form 25 filed by Orion Biotech Opportunities Corp.
- Orion Biotech Opportunities Says Will Redeem Public Share, Will Not Consummate Initial Business Combination
- Orion Biotech Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by Orion Biotech Opportunities Corp.